Company / Cost of Revenue
Nutex Health, Inc. Cost of Revenue History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$14.6M
FY2021
5-year range
$14.6M / $14.6M
FY2017-FY2021
Trend
+1510.0%
vs FY2020
Sector context
#233 of 237
Industrials
What the data says
Cost of Revenue changed +1510% YoY in FY2021, a notable deviation from the 4-year average annual change of +787%.
Based on SEC 10-K filings.
$15M in FY2021 with a 3-year CAGR of +206.7%.
Increased from $830,443 to $15M over the past 2 years.
Industrials sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +206.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in IndustrialsTop 2% of 237This company $14.6M Sector average $4.5B
▼
-99.7% below sector average
Key checks
Key Insights
- Nutex Health, Inc.'s cost of revenue has grown for 4 consecutive years.
- 3-year CAGR of +206.7%, indicating consistent growth.
- In FY2021, cost of revenue increased 1510.0% year-over-year.
- Ranks #233 out of 237 companies in the Industrials sector.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $14.6M | +1510.0% |
| FY2020 | $909.8K | +9.6% |
| FY2019 | $830.4K | +63.6% |
| FY2018 | $507.6K | +1565.4% |
| FY2017 | $30.5K | - |
| FY2016 | $0 | -100.0% |
As of FY2021 · SEC 10-K · Updated Mar 28, 2026